Skip to content

A pilot, randomized, placebo-controlled study of mindfulness meditation in treating insomnia in multiple sclerosis.

Joseph B Guarnaccia, Valentine Y Njike, Anne Dutton, Rockiy G Ayettey, Judith A Treu, Beth P Comerford, Rajita Sinha

BMC Neurology July 11, 2023 DOI: 10.1186/s12883-023-03309-0 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Placebo-controlled Pilot study Peer reviewed
Sample size 53
Population Persons with multiple sclerosis reporting chronic insomnia
Interventions Mindfulness Based Stress Intervention for Insomnia (MBSI-I) sleep hygiene
Duration 10-week intervention with assessments at 10 and 16 weeks
Measures Pittsburg Sleep Quality Rating Scale (PSQI), Insomnia Severity Index (ISI), Multiple Sclerosis Quality of Life Inventory (MSQLI)
Topics Meditation
Keywords Fatigue Insomnia Multiple sclerosis Sleep hygiene Sleep quality
Registration NCT03949296
Key findings Mindfulness training did not significantly improve sleep efficiency or self-reported sleep quality compared with sleep hygiene, but insomnia severity improved more with mindfulness at 10 weeks (not 16 weeks), and within-group improvements in sleep quality and insomnia severity appeared in the mindfulness cohorts at both time points. Several quality-of-life measures, including fatigue, mental health, and cognitive function, favored the mindfulness cohorts.

Abstract

Mindfulness is an established approach to reduce distress and stress reactivity by improving awareness and tolerability of thoughts and emotions. This study compares mindfulness training to sleep hygiene in persons with multiple sclerosis (PWMS) who report chronic insomnia, examining sleep efficiency (SE), self-reported sleep quality and quality of life. Fifty-three PWMS were randomized (1:1) in a single-blinded, parallel group design to ten, two-hour weekly sessions of Mindfulness Based Stress Intervention for Insomnia (MBSI-I) over a span of ten weeks or a single, one hour sleep hygiene (SH) session over one day. The primary outcome measure was SE, measured by the Fitbit™ Charge 2 wrist device, at 10 and 16 weeks from the start of study interventions. Self-report outcomes included the Pittsburg Sleep Quality Rating Scale (PSQI), Insomnia Severity Index (ISI) and the Multiple Sclerosis Quality of Life Inventory (MSQLI). Nineteen participants in the MBSI-I group and 24 in the SH group completed the primary study. Subsequently, ten participants in the original SH group participated in the 10-week MSBI-I course and their data was added to the MBSI-I cohort (eMSBI-I). While neither SE nor the PSQI showed significant differences between MBSI-I, eMBSI-I and SH groups, ISI improved in both the MSBI-I and eMBSI-I vs SH at 10 weeks (p = 0.0014 and p = 0.0275) but not 16 weeks. However, pre and post assessments within the MBSI-I and eMBSI-I cohorts did show significant improvement in the PSQI and ISI at 10 and 16 weeks, while SH was significant in the ISI only at 16 weeks. Several quality of life measurements, including fatigue, mental health and cognitive function favored the mindfulness cohorts. This pilot study demonstrates beneficial effects of MBSR on insomnia, sleep quality and quality of life in PWMS. NCT03949296. 14 May 2019.

Comparable studies

Other randomized controlled trials on meditation, most cited first.

Study Year Design Participants
Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment 2003 Randomized controlled trial n = 41
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults 2008 Randomized controlled trial n = 139
Short-term meditation training improves attention and self-regulation Undergraduate Chinese students 2007 Randomized controlled trial n = 40
Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients 2004 Randomized controlled trial n = 73

Citations in the library

Explore topics